🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Diane G. Kanjilal

World Wide Web Consortium

ORCID: 0000-0001-7300-5556

Also affiliated with Massachusetts General Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.3Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

PLoS ONE(2023)10.1371/journal.pone.0286297
Top 16%
1.3DataRank
Top 16%62 citations

Tanayott Thaweethai, Shari B. Brosnahan, Mine Cicek, Megan L. Fitzgerald, Jason D. Goldman +95 more

Papers

Driven by 7 papers — median percentile 84. Top paper: “Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial”.

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Nature Medicine(2022)10.1038/s41591-022-01815-1
N/A
2.7DataRank · unranked
143 citations

Kathryn E. Stephenson, Kshitij Wagh, Sabrina C. Tan, Rebecca Zash, Stephen R. Walsh +32 more

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature Medicine(2021)10.1038/s41591-021-01509-0
N/A
2.3DataRank · unranked
104 citations

Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle +35 more

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

The Lancet Infectious Diseases(2020)10.1016/s1473-3099(20)30085-2
N/A
2.1DataRank · unranked
58 citations

Chen Sabrina Tan, Stephen R. Walsh, Andrew J. Hale, Jessica L. Ansel, Diane G. Kanjilal +21 more

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

PLoS ONE(2023)10.1371/journal.pone.0286297
Top 16%
1.3DataRank
Top 16%62 citations

Tanayott Thaweethai, Shari B. Brosnahan, Mine Cicek, Megan L. Fitzgerald, Jason D. Goldman +95 more

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)

The Lancet HIV(2020)10.1016/s2352-3018(20)30001-1
N/A
0.934DataRank · unranked
25 citations

Frank Wegmann, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +27 more

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy

npj Vaccines(2024)10.1038/s41541-024-00876-2
N/A
0DataRank · unranked
7 citations

Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +24 more

“I’m a really hard stick”: barriers, facilitators, and preferences in emergency department HIV testing among people who inject drugs

AIDS Care(2025)10.1080/09540121.2025.2536183
N/A
0DataRank · unranked
0 citations

Christina Psaros, Laura Kehoe, Wendy Macias‐Konstantopoulos, Robert A. Parker, Diane G. Kanjilal +5 more